Sensei Biotherapeutics Inc
F:407

Watchlist Manager
Sensei Biotherapeutics Inc Logo
Sensei Biotherapeutics Inc
F:407
Watchlist
Price: 5.2 EUR
Market Cap: 138.2m EUR

Operating Margin
Sensei Biotherapeutics Inc

0%
Current
0%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-25.6m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Sensei Biotherapeutics Inc
Glance View

Market Cap
138.2m EUR
Industry
Biotechnology

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation of immunotherapies for the treatment of cancer and infectious diseases. The company is headquartered in Gaithersburg, Maryland and currently employs 56 full-time employees. The company went IPO on 2021-02-04. The firm is engaged in the discovery and development of therapies with focus on treatments for cancer. Its ImmunoPhage platform is a self-adjuvanted and differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused and coordinated innate and adaptive immune response. The firm is engineering its ImmunoPhage product candidates to directly target antigen presenting cells (APCs) and modulate the tumor microenvironment (TME) through the targeted use of nanobodies which enhances therapeutic activity. SNS-301 is an ImmunoPhage product candidate that the Company is developing as a treatment for locally advanced unresectable or metastatic squamous cell carcinoma of the head and neck (SCCHN). The company also develops ImmunoPhage candidate, SNS-401, for the treatment of Merkel cell carcinoma (MCC). The firm is also engaged in developing a monoclonal antibody (mAb) therapy.

Sensei Biotherapeutics Inc Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-25.6m
/
Revenue
0
What is the Operating Margin of Sensei Biotherapeutics Inc?

Based on Sensei Biotherapeutics Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top